BioSense

<h2 id="biosense-mandate-and-establishment">BioSense mandate and establishment</h2>
<p>Mandated in the <a href="/facts/Public_Health_Security_and_Bioterrorism_Preparedness_Response_Act/p4Ht9Akw">Public Health Security and Bioterrorism Preparedness Response Act</a> of 2002, the CDC BioSense Program was launched in 2003 to establish an integrated national public health surveillance system for early detection and rapid assessment of potential <a href="/facts/Bioterrorism/YW2rmVls">bioterrorism</a>-related illness.<a class="footnote-ref" id="fnref:8" href="#fn:8"><sup>8</sup></a>
</p>
<h2 id="biosense-20">BioSense 2.0</h2>

<p>By November 2011, the Redesigned BioSense (or BioSense 2.0) will develop a community-controlled environment (architecturally distributed in a cloud-based model) governed by the Association of State and Territorial Health Officials (ASTHO), in coordination with the <a href="/facts/Council_of_State_and_Territorial_Epidemiologists/rKy9kVV2">Council of State and Territorial Epidemiologists</a> (CSTE), <a href="/facts/National_Association_of_County_and_City_Health_Officials/Fvnea1JD">National Association of County and City Health Officials</a> (NACCHO), and International Society for Disease Surveillance (ISDS).  ASTHO will offer this service to states for receiving and managing <a href="/facts/Syndromic_surveillance/bBhE6Xyd">syndromic surveillance</a> information.
</p><p>The cloud-based BioSense 2.0 environment allows State and Local health departments to access data that will support potential expansions of their syndromic surveillance systems under the Meaningful Use program. States that elect to use this utility will each have a secure "zone" that they control and can use to manage or share their syndromic surveillance information.
<a class="footnote-ref" id="fnref:9" href="#fn:9"><sup>9</sup></a>
</p>

<h2 id="references">References</h2>

<ol>
<li id="fn:1"><p>Mitka, Mike (2009-01-14). "BioSense Program". JAMA. 301 (2): 152. doi:10.1001/jama.2008.881. ISSN 0098-7484. <a href="http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2008.881" target="_blank">http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2008.881</a> <a href="#fnref:1" class="footnote-back-ref">↩</a></p></li>
<li id="fn:2"><p>McCay, Betsy (March 9, 2006). "Hospital Link Could Catch Outbreaks Early". Wall Street Journal. <a href="https://www.wsj.com/articles/SB114186869834793251" target="_blank">https://www.wsj.com/articles/SB114186869834793251</a> <a href="#fnref:2" class="footnote-back-ref">↩</a></p></li>
<li id="fn:3"><p>"Biosense or Biononsense". The Scientist Magazine®. Retrieved 2024-08-16. <a href="https://www.the-scientist.com/biosense-or-biononsense-46646" target="_blank">https://www.the-scientist.com/biosense-or-biononsense-46646</a> <a href="#fnref:3" class="footnote-back-ref">↩</a></p></li>
<li id="fn:4"><p>Farr, Christina (2020-04-04). "These 'disease hunters' developed a novel technique for tracking pandemics after 9/11, but lost funding right before COVID-19". CNBC. Retrieved 2024-08-16. <a href="https://www.cnbc.com/amp/2020/04/04/syndromic-surveillance-useful-to-track-pandemics-like-covid-19.html" target="_blank">https://www.cnbc.com/amp/2020/04/04/syndromic-surveillance-useful-to-track-pandemics-like-covid-19.html</a> <a href="#fnref:4" class="footnote-back-ref">↩</a></p></li>
<li id="fn:5"><p>Buehler, James W.; Whitney, Ellen A.; Smith, Donna; Prietula, Michael J.; Stanton, Sarah H.; Isakov, Alexander P. (June 2009). "Situational Uses of Syndromic Surveillance". Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. 7 (2): 165–177. doi:10.1089/bsp.2009.0013. ISSN 1538-7135. PMID 19635001. <a href="http://www.liebertpub.com/doi/10.1089/bsp.2009.0013" target="_blank">http://www.liebertpub.com/doi/10.1089/bsp.2009.0013</a> <a href="#fnref:5" class="footnote-back-ref">↩</a></p></li>
<li id="fn:6"><p>Hartnett, Kathleen P.; Kite-Powell, Aaron; Patel, Megan T.; Haag, Brittani L.; Sheppard, Michael J.; Dias, Taylor P.; King, Brian A.; Melstrom, Paul C.; Ritchey, Matthew D.; Stein, Zachary; Idaikkadar, Nimi; Vivolo-Kantor, Alana M.; Rose, Dale A.; Briss, Peter A.; Layden, Jennifer E. (2020-02-20). "Syndromic Surveillance for E-Cigarette, or Vaping, Product Use–Associated Lung Injury". New England Journal of Medicine. 382 (8): 766–772. doi:10.1056/NEJMsr1915313. ISSN 0028-4793. PMC 10613510. PMID 31860794. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613510" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613510</a> <a href="#fnref:6" class="footnote-back-ref">↩</a></p></li>
<li id="fn:7"><p>"BioSense". cdc.gov. Retrieved 26 May 2015. <a href="https://www.cdc.gov/biosense/" target="_blank">https://www.cdc.gov/biosense/</a> <a href="#fnref:7" class="footnote-back-ref">↩</a></p></li>
<li id="fn:8"><p>"BioSense". cdc.gov. Retrieved 26 May 2015. <a href="https://www.cdc.gov/biosense/" target="_blank">https://www.cdc.gov/biosense/</a> <a href="#fnref:8" class="footnote-back-ref">↩</a></p></li>
<li id="fn:9"><p>"BioSense Redesign Collaboration Site". biosenseredesign.org. Archived from the original on 15 December 2015. Retrieved 26 May 2015. <a href="https://web.archive.org/web/20151215030557/http://www.biosenseredesign.org/" target="_blank">https://web.archive.org/web/20151215030557/http://www.biosenseredesign.org/</a> <a href="#fnref:9" class="footnote-back-ref">↩</a></p></li>
</ol>

BioSense open-in-new

BioSense